PubMed Trending Research Digest — May 22, 2026

Automated digest · 96 articles · 15 research areas · May 22, 2026

Overview

Across this week’s PubMed set, a dominant thread is precision medicine built on better stratification: multiple studies develop or validate risk models and biomarkers (e.g., SABRE for SGLT2i heart-failure prevention in lower-risk type 2 diabetes, an epidemiological risk score for early pancreatic cancer surveillance, MS-based measurable residual disease in multiple myeloma, and transcriptomic predictors of response in neoadjuvant TNBC). Parallel work emphasizes that “real-world” implementation matters—living guidelines for multiple myeloma and deprescribing guidance for adult ADHD, plus registry-based effectiveness analyses for therapies such as cilta-cel in earlier vs later lines.

A second major theme is immune modulation for cancer and beyond. Solid-tumor adoptive cellular therapy is moving into “primetime” with new FDA approvals and engineering strategies (e.g., KLF4-enhanced CAR T durability, peri-transplant BiTE use, and dual-target CAR T for high-risk myeloma). Mechanistic immunology studies also target resistance and improve antitumor efficacy—such as neural–immune control of lung cancer tertiary lymphoid structures, overcoming NECTIN4-ADC resistance via endocytic uptake pathways, and reprogramming exhausted or immunosuppressed T cells (PARK7 and SIK inhibition). Complementing these, several studies focus on cancer biology at the systems level: human-relevant PDAC initiation models, intercellular propagation of genome instability signals, and lactate/lactylation as a metabolic-epigenetic driver of tumor behavior.

Finally, the digest highlights cross-cutting advances in mechanistic biology and translational tools. Neurobiology and sleep research connect circuits and neuromodulators to dementia risk and stress-related sleep disruption, while neurodegeneration studies implicate pathways such as ZBP1/Z-RNA signaling in tau-driven death. In parallel, microbiome and infectious disease work spans from post-dengue sequelae differentiation to viral/bacterial entry and restriction mechanisms, and even microbiome epigenetic phase variation. Methodologically, the set includes advances in computational/AI approaches (explainable AI for imaging, foundation-model phenotyping via MouseMapper, and spatial transcriptomics segmentation) and in genome editing delivery and efficiency (prime editing motif optimization, VLP-based Cas9 delivery), underscoring a broader push toward scalable, safer, and more actionable biomedical interventions.

---

Living Clinical Guidelines & Treatment Recommendations

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

This observational cohort study compared the effectiveness of ocrelizumab versus fingolimod, natalizumab, and alemtuzumab across predefined clinical and demographic subgroups in relapse-onset multiple sclerosis (MS) using data from MSBase, OFSEP, and the Danish MS Registry. The key finding (from pairwise comparisons across 14 subgroups) was that treatment effects varied by subgroup characteristics, with ocrelizumab showing comparative outcomes in relapse and progression measures relative to other disease-modifying therapies (details truncated in abstract). Clinically, subgroup-aware comparative effectiveness can guide more personalized selection of CD20+ B-cell–targeted therapy in MS.

Roos I, Sharmin S, Horakova D et al. · Journal of neurology, neurosurgery, and psychiatry · (2026) · View on PubMed ↗ · Free PDF ↗

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD✰.

This article studied expert consensus on when and how to deprescribe stimulant medications in adults with ADHD, using a focused literature review and a 2-round Delphi survey of 45 international psychopharmacology experts. Consensus (≥75% agreement) was reached on 10 of 11 Delphi statements regarding deprescribing considerations for adult ADHD stimulants. The resulting ASCP task force guidance is clinically significant because it standardizes decision-making about potentially indefinite stimulant use and supports safer, more individualized deprescribing practices.

Goodman DW, Mago R, Citrome L et al. · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · (2026) · View on PubMed ↗

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

This ASCO Living Guideline (version 2026.1.1) studied evidence-based treatment recommendations for multiple myeloma across clinical practice, updated by an expert panel using ASCO’s living-guideline methodology. The key finding is that the guideline provides continuously revised, systematically reviewed recommendations for multiple myeloma treatment as new data emerge. Clinically, it supports oncologists in selecting therapies while emphasizing that the guideline does not replace individualized clinical judgment and does not account for patient-level variation.

Banerjee R, Cheung MC, Derman B et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · (2026) · View on PubMed ↗

---

Adoptive Cell Therapy for Cancer (TIL/TCR/CAR-T/CAR-NK/Other)

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

The study evaluated peripheral measurable residual disease (MRD) detection using MALDI-TOF mass spectrometry in newly diagnosed multiple myeloma patients enrolled in the phase III GMMG-HD7 trial, analyzing 3,301 serum samples from 617 patients. The key finding was that MS-based measurable residual activity reliably distinguished therapeutic antibodies, tracked diagnostic M proteins longitudinally, and showed strong prognostic value, with MS negativity associated with improved progression-free survival (greatest separation at later time points such as 12 months of maintenance). This is significant because it supports a minimally invasive, prospective MS workflow for MRD risk stratification in MM.

Jin JX, Ginde VR, Huhn S et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · (2026) · View on PubMed ↗

Anti-BCMA/GPRC5D CAR T in relapsed or refractory multiple myeloma patients with extraosseous extramedullary disease.

The study evaluated anti-BCMA/GPRC5D bispecific CAR T cells in 37 relapsed or refractory multiple myeloma (RRMM) patients with extraosseous extramedullary disease (EMD) in a single-arm, open-label phase 2 trial. The key finding was that 36 of 37 patients (97%) achieved overall response with measurable residual disease (MRD) negativity, including 16 (43%) with complete response (truncated abstract limits further detail). Clinically, this suggests that dual-targeting BCMA and GPRC5D CAR T can produce high response rates in a high-risk RRMM subgroup with limited effective options.

Zhou D, Qi Y, Ma S et al. · Blood · (2026) · View on PubMed ↗

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.

This report described prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after relapse following CAR T-cell therapy. The key finding was that glofitamab achieved durable clinical benefit in this post–CAR T relapse setting, as reflected by extended survival. If confirmed in larger cohorts, this would position glofitamab as a potential salvage strategy after CAR T failure in aggressive B-cell lymphoma.

Sesques P, Houot R, Al Tabaa Y et al. · Haematologica · (2026) · View on PubMed ↗ · Free PDF ↗

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis.

This nationwide registry analysis studied real-world outcomes of the BCMA-directed CAR T-cell therapy ciltacabtagene autoleucel (cilta-cel) in patients with relapsed or refractory multiple myeloma (RRMM) receiving standard-of-care cilta-cel between 2022 and (truncated) and compared earlier versus later lines of therapy. The key finding was that outcomes differed by line of treatment, with the earlier-line indication showing results consistent with improved effectiveness relative to later-line use in routine practice. These real-world data support the clinical significance of cilta-cel’s label expansion into earlier lines for RRMM and help clinicians anticipate benefit outside randomized trial settings.

Gagelmann N, Einsele H, Flossdorf S et al. · Journal of hematology & oncology · (2026) · View on PubMed ↗ · Free PDF ↗

KLF4 overexpression in CAR T cells enhances antitumor potency by preventing exhaustion.

This study investigated whether overexpressing the transcription factor KLF4 in chimeric antigen receptor (CAR) T cells improves antitumor activity and persistence in models of refractory/relapsed lymphoma or leukemia. KLF4 overexpression enhanced CAR T-cell function and durability while preventing exhaustion, supported by in vitro stimulation assays, RNA sequencing, and antitumor validation in mouse models. The results suggest a gene-engineering approach (KLF4) to improve the durability of CAR T-cell therapies.

Wang H, Meng X, Feng Y et al. · Journal for immunotherapy of cancer · (2026) · View on PubMed ↗ · Free PDF ↗

“Immunologic Dream Team”: BiTEs peri-allotransplant to redirect donor lymphocytes towards GVL.

This case report studied peri-allotransplant use of bispecific T cell engager (BiTE) therapy to redirect donor lymphocytes toward graft-versus-leukemia (GVL) in a patient undergoing allogeneic stem cell transplantation, using glofitamab (CD20×CD3) as the BiTE. The authors report the first literature case of successful treatment with glofitamab in this peri-transplant context to enhance anti-tumor activity. The clinical significance is that it suggests a potential strategy to improve post-transplant outcomes by strengthening graft-versus-tumor effects in relapsed/refractory B-cell malignancies.

Iovino L, Shadman M, Milano F et al. · Blood advances · (2026) · View on PubMed ↗ · Free PDF ↗

Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

This review studied the current state of adoptive cellular therapies (ACT) for solid tumors, focusing on recent FDA-approved platforms and their translation from hematologic malignancies to solid cancers. The key finding is that in 2024 the FDA approved lifileucel (tumor-infiltrating lymphocyte therapy) for advanced melanoma and afamitresgene autoleucel (engineered T-cell receptor therapy) for synovial sarcoma, marking ACT’s clinical arrival in solid tumors. Scientifically and clinically, it highlights readiness for “primetime” ACT in solid tumors and outlines expanding platforms including TIL, TCR, CAR-T, CAR-NK, and CAR-macrophage approaches.

Maiocco G, Ernani V, Gustafson MP et al. · JCO oncology practice · (2026) · View on PubMed ↗

---

Cancer Immunotherapy & Biomarkers (Non–cell-therapy)

Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer.

The study examined mechanisms of resistance to the NECTIN4-targeting antibody-drug conjugate enfortumab vedotin (NECTIN4-ADC) in urothelial carcinoma by integrating paired spatial transcriptomics (pre- vs post-NECTIN4-ADC plus anti–PD-1), humanized mouse models, single-cell RNA-seq, and resistant cell systems. The key finding was that resistant tumor cells showed increased NECTIN4 expression but defective ADC uptake, and mechanistically the enzyme AKR1C1 bound NECTIN4 and impaired AP2M1-dependent clathrin-mediated internalization. This is clinically significant because it points to endocytic/AKR1C1–AP2M1 pathways as actionable determinants to overcome ADC resistance.

Wang Y, Chen Z, Wang W et al. · Cancer cell · (2026) · View on PubMed ↗

Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical Trial.

The study tested whether adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improves overall survival in gastric cancer patients with peritoneal metastasis in the multicenter open-label phase 3 DRAGON-01 randomized clinical trial. The key finding was the survival impact of the intraperitoneal paclitaxel intensification strategy compared with the standard intravenous paclitaxel plus S-1 regimen (primary results are truncated in the abstract). If beneficial, this would establish a new evidence-based chemotherapy approach that leverages higher peritoneal drug exposure to improve outcomes in a poor-prognosis disease setting.

Yan C, Yang Z, Shi Z et al. · JAMA oncology · (2026) · View on PubMed ↗

Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study.

This phase 2, multicenter single-arm trial studied camrelizumab (200 mg every 3 weeks) plus famitinib (20 mg daily) in patients with refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after progression on platinum-based chemotherapy. The key reported outcome was objective response rate (ORR) with secondary endpoints including progression-free survival (PFS) and duration of response (DOR), but the abstract text provided is truncated before results. If efficacy and safety are favorable, this combination could offer a post-platinum treatment option targeting PD-1 signaling (camrelizumab) and angiogenesis (famitinib) in this biomarker-agnostic population.

Xu B, Zhu G, Lu J et al. · Cancer medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial.

The NeoTRIPaPDL1 trial study performed longitudinal transcriptomic profiling to identify predictors of response to neoadjuvant chemoimmunotherapy in 280 patients with high-risk triple-negative breast cancer (TNBC) receiving carboplatin plus nab-paclitaxel with or without atezolizumab. The key finding was that baseline and on-treatment RNA sequencing–derived gene signatures (including immune-related and ferroptosis-related signatures) could stratify likelihood of response to the atezolizumab-containing regimen. This is clinically significant because it provides mechanistic, transcriptome-based biomarkers to guide patient selection and potentially adapt neoadjuvant immunotherapy in TNBC.

Dugo M, Huang CS, Egle D et al. · Annals of oncology : official journal of the European Society for Medical Oncology · (2026) · View on PubMed ↗

Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

The study examined how coupling dead cell recognition to Fcγ receptors can augment anticancer immunity, focusing on type 1 conventional dendritic cells (cDC1s) and FcγR-bridging reagents in human and murine tumor models. It showed that bridging F-actin on necrotic debris to Fcγ receptors—via an Fc-DNGR-1 fusion protein or an anti-F-actin antibody—redirects abundant tumor-associated APCs (including cDC2s and monocyte-derived cells) to internalize necrotic material and cross-present antigens. This expands the pool of antigen-presenting cells that can drive CD8+ T-cell responses, potentially overcoming the scarcity of cDC1s in tumors.

Castro-Dopico T, Piot C, Buck MD et al. · Nature cancer · (2026) · View on PubMed ↗ · Free PDF ↗

PARK7-induced delactylation of ATAD3A impairs mitochondrial fitness to promote exhaustion of tumor-infiltrating CD8+ T cells.

The study investigated how PARK7 regulates mitochondrial fitness and exhaustion of tumor-infiltrating CD8+ T cells, using T-cell-specific PARK7 deficiency and mechanistic assays involving the mitochondrial membrane protein ATAD3A. PARK7 was enriched in mitochondria of tumor-infiltrating CD8+ T cells, and loss of PARK7 improved mitochondrial function, reduced T-cell exhaustion, and suppressed tumor growth. Mechanistically, PARK7 interacted with ATAD3A and downregulated its lactylation, linking PARK7–ATAD3A post-translational regulation to mitochondrial dysfunction and impaired antitumor immunity.

Liu J, Xu M, Zhou Y et al. · Cellular & molecular immunology · (2026) · View on PubMed ↗

Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

The study tested whether inhibiting salt-inducible kinases (SIKs) can reprogram T cells and restore antitumor immunity in ovarian cancer, using patient ascites-derived human T cells and syngeneic mouse models of resistant high-grade serous ovarian carcinoma. SIK inhibition reprogrammed human T cells to strongly activate antitumor responses and, in mice, genetic ablation or pharmacologic SIK inhibition improved survival, with enhanced benefit when combined with PD-1 blockade. These results identify SIKs (upstream of immunosuppression involving LKB1) as therapeutic targets to overcome immunotherapy resistance in ovarian cancer.

Dong H, Ray A, Rotter LK et al. · Nature immunology · (2026) · View on PubMed ↗

Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer.

This study examined how nociceptive sensory innervation regulates lung adenocarcinoma (LUAD) progression and tertiary lymphoid structure (TLS) formation. LUAD increased nociceptive input and CGRP release, which acted on macrophages to impair CXCL13+ fibroblast recruitment and block TLS assembly; sensory denervation restored TLS, enhanced B and T cell immunity, and suppressed tumor growth. The work identifies a neural–immune axis (CGRP–macrophage–TLS) as a potential therapeutic lever in lung cancer.

Ho YH, Bregni G, Stazi M et al. · Cell · (2026) · View on PubMed ↗ · Free PDF ↗

Explainable AI in Cancer Imaging: Scoping Review of Methods, Modalities, and Clinical Integration.

This scoping review studied explainable AI (xAI) methods applied to radiologic cancer imaging, mapping techniques, imaging modalities, validation approaches, and clinical integration practices across published studies. It found that evidence on how explainability is implemented, validated, and reported remains fragmented, with persistent gaps in validation and real-world integration. The review is clinically significant because it highlights where xAI for oncology imaging needs stronger methodological rigor before routine clinical deployment.

Fotopoulos D, Ladakis I, Filos D et al. · Journal of medical Internet research · (2026) · View on PubMed ↗ · Free PDF ↗

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

This multicenter single-arm phase II trial studied atezolizumab monotherapy in 14 patients with relapsed/refractory extranodal NK/T-cell lymphoma (ENKTL). The independent review committee assessed an objective response rate (ORR) of 54% (7/13 evaluable), including 4 complete responses (31%). The trial is clinically significant because it provides efficacy and safety evidence for PD-L1 blockade as a treatment option in a rare lymphoma with limited therapies.

Makita S, Koya J, Suzuki Y et al. · Blood advances · (2026) · View on PubMed ↗ · Free PDF ↗

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

This preclinical/translation-focused study investigated a PBD-dimer–containing antibody drug conjugate (ADC) targeting CCRL2 in high-risk myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML), including TP53-mutated disease. The work leveraged the finding that CCRL2 is overexpressed in MDS and secondary AML and that TP53-mutated MDS/AML and AML with erythroid features show the highest CCRL2 levels, then developed an anti-CCRL2 ADC conjugated to a cytotoxic payload (pyrrolo…). The scientific significance is that it supports CCRL2 as a therapeutic target and provides a rationale for ADC-based treatment in poor-prognosis, TP53-mutated MDS/AML.

Naji NS, Ahmedna TS, Zeng X et al. · Blood advances · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cancer Genomics, Models & Mechanisms (PDAC, DNA damage, metastasis, etc.)

Hepatic SNHG9 links gut microbiota to liver protection in drug-induced liver injury.

The study examined whether the hepatic long non-coding RNA SNHG9 mediates gut microbiota effects on acetaminophen (APAP)-induced drug-induced liver injury (DILI), using mechanistic experiments in a liver injury model. Hepatic SNHG9 upregulation protected against APAP hepatotoxicity by activating MAS (a G protein-coupled receptor) to enhance clearance of cellular damage through increased autophagy, and SNHG9 was reported to bind to insulin-like growth [factor]-related components (truncated in abstract). Scientifically, it links microbiota-driven regulation to a defined hepatic lncRNA–MAS–autophagy axis, suggesting SNHG9/MAS as potential therapeutic targets for DILI.

Bao W, Hang B, Zeng D et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Multifaceted roles of PDS5B in RAD51-dependent homology-directed DNA repair and replication fork protection.

This work studied the DNA repair and replication fork protection roles of PDS5B in RAD51-dependent homologous recombination (HR), using biochemical DNA-binding assays and functional synergy tests with BRCA2-DSS1 and MRE11-RAD50-NBS1 digestion pathways. PDS5B preferentially binds double-stranded DNA, enhances RAD51-mediated strand exchange by capturing dsDNA, synergizes with BRCA2-DSS1 to overcome RPA interference, and cooperates with RAD51 to protect dsDNA from MRE11-RAD50-NBS1-mediated digestion. These results expand PDS5B from a cohesion/genome organizer to an active mediator of HR and replication fork stress resistance, informing how genome stability is preserved in DNA damage contexts.

Katz JN, Samentar L, Fang Q et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation.

This study used pluripotent stem cell–derived pancreatic progenitor organoids to model early pancreatic ductal adenocarcinoma (PDAC) transformation and to define genetic/epigenetic barriers to tumor initiation in human systems. It found that CDKN2A loss—nearly universal in patients but dispensable in mouse models—was essential for neoplastic transformation when combined with KRAS and TP53 mutations, while SMAD4 loss promoted progression, supported by multi-omics profiling and validation against clinical datasets and histopathology. These results provide a human-relevant initiation model that can improve understanding of which driver combinations truly trigger early PDAC.

Zhang X, Wong W, Cho HS et al. · Developmental cell · (2026) · View on PubMed ↗

Genome instability triggers intercellular DNA transfer between human cells.

This Cell study investigated whether cytoplasmic DNA generated by genome instability can act non–cell-autonomously in nearby human cells. It showed that cytoplasmic DNA transfers between adjacent human cells through contact-dependent, cytoskeleton-based nanotubes, triggered by diverse genome instability sources including mitotic spindle poisons, ionizing radiation, and Cas9-induced chromosome breakage. The findings reveal a mechanism for intercellular propagation of DNA damage signals, with implications for how genome instability can spread phenotypic effects in tissues.

Maurais EG, Mazzagatti A, Lin YF et al. · Cell · (2026) · View on PubMed ↗ · Free PDF ↗

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project.

This study developed and validated an epidemiological risk score (ERS) for early detection of pancreatic ductal adenocarcinoma in high-risk individuals within the IMAGene project. The key finding is that the ERS—constructed from a meta-analysis of 24 established epidemiological risk factors—was applied to a prospective cohort of 178 individuals with a family history of PDAC to assess predictive performance prior to imaging or diagnostic procedures. Scientifically and clinically, it provides a non-imaging risk stratification tool that could help select high-risk people for earlier surveillance and diagnostic workup.

Riobó-Mayo L, Salvador L, Teulé A et al. · International journal of epidemiology · (2026) · View on PubMed ↗

---

Neural Circuits, Sleep & Neurodegeneration

Genetic associations between post-traumatic stress disorder and REM-sleep behavior disorder.

The study analyzed genetic overlap between post-traumatic stress disorder (PTSD) and isolated/idiopathic REM sleep behavior disorder (iRBD) using polygenic risk scores (PRS), genetic correlation, and Mendelian randomization, and additionally examined dopamine transporter imaging binding status in iRBD patients with PTSD (N=6) versus without PTSD (N=32). The key finding was that the genetic analyses did not support a causal relationship between PTSD and iRBD, while clinical imaging comparisons were used to probe neurobiological differences between groups. These results refine whether PTSD is genetically causal for iRBD and inform how shared dopaminergic vulnerability might contribute to comorbidity.

Ghamgosar Shahkhali M, Liu L, Ghamgosar Shahkhali MH et al. · NPJ Parkinson’s disease · (2026) · View on PubMed ↗

Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

This systematic analysis of Global Burden of Disease Study 2023 estimates assessed global trends in prevalence, incidence, and health burden for 12 mental disorders across 21 regions, 204 countries/territories, sexes, ages, and SDI quintiles from 1990 to 2023. The key finding was updated, cross-country temporal patterns in mental-disorder burden, including differences by disorder type, demographic group, and development level. The work is significant for guiding public-health prioritization and tracking progress toward mental-health targets over time.

Lancet (London, England) · (2026) · View on PubMed ↗

The oscillatory biology of sleep: Linkage to dementia.

This article synthesized evidence on how sleep reorganizes neuromodulator activity into coordinated brain rhythms, linking oscillatory neuromodulator dynamics to dementia risk. The key finding highlighted synchronized ~50-second oscillations in norepinephrine, acetylcholine, serotonin, and dopamine during sleep, phase-coupled to cerebrospinal fluid flow and associated with glymphatic clearance via slow vasomotion. The significance is that disrupted neuromodulator signaling and sleep-linked clearance/oscillation mechanisms may contribute to neurodegenerative processes underlying dementia.

Nedergaard M · Science (New York, N.Y.) · (2026) · View on PubMed ↗

A plasma protein signature for cerebral amyloid angiopathy.

This study investigated whether a plasma protein signature can serve as an in vivo biomarker for cerebral amyloid angiopathy (CAA), a major risk factor for intracerebral hemorrhage and cognitive decline and a contributor to amyloid-related imaging abnormalities (ARIA) in anti-amyloid Alzheimer’s disease therapies. The key finding was identification of a blood-based protein pattern that discriminates CAA status with potential clinical utility for antemortem detection. This is scientifically and clinically significant because it could enable safer selection and monitoring of patients receiving disease-modifying anti-amyloid treatments.

Singh A, Denkinger MN, Leuzy A et al. · Acta neuropathologica · (2026) · View on PubMed ↗ · Free PDF ↗

Recent Developments in the Drug Treatment of Parkinson’s Disease.

This review examined recent pharmacological treatment advances for Parkinson’s disease (PD), focusing on recently approved drugs, delivery approaches, and agents in clinical development for patients with PD. It highlights that dopamine substitution remains the mainstay while newer therapies and delivery modes aim to improve symptom control and address disease progression more effectively. These developments are clinically significant because they inform current and emerging treatment strategies for a common, progressive neurodegenerative disorder driven by α-synuclein pathology and nigrostriatal dysfunction.

Leiter S, Mahlknecht P, Poewe W · Drugs · (2026) · View on PubMed ↗ · Free PDF ↗

Astrocyte glucocorticoid receptor signalling restricts neuronal plasticity.

This study examined how astrocyte glucocorticoid receptor (GR) signalling restricts neuronal plasticity during postnatal development in the mouse primary visual cortex. Using paired single-cell transcriptomics and chromatin accessibility sequencing, the authors found that light exposure drives astrocyte maturation via cell-type-specific recruitment of GR-dependent gene programs, thereby limiting experience-dependent plasticity. The results are clinically relevant because they identify a specific astrocyte GR pathway that could be targeted to modulate developmental or stress-related impairments in neural plasticity.

Gegenhuber B, Sonoda T, Traunmüller L et al. · Nature · (2026) · View on PubMed ↗ · Free PDF ↗

Dopamine drives persistent remodelling of the maternal brain.

This study investigated how dopamine drives persistent remodelling of the maternal brain, focusing on reproductive-experience–induced neuroplasticity. Using brain-wide transcriptomic profiling and single-cell RNA sequencing with a maternal–pup separation paradigm, the authors identified the dorsal hippocampal formation (dHF) as a key site of transcriptional remodelling and showed that chronic postpartum stress disrupts these adaptations. The findings are clinically significant because they link dopamine-mediated molecular changes to long-lasting postpartum brain plasticity and to how stress can impair it.

O’Chan JC, Di Salvo G, Cunningham AM et al. · Nature · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

Tau aggregates cause reactivation of transposable DNA elements, leading to Z-RNA-ZBP1-mediated neuronal death.

The study investigated tau aggregate–driven neurodegeneration in the PS19 mouse model, focusing on Z-RNA–ZBP1 signaling and reactivation of transposable DNA elements. Tau aggregates triggered ZBP1 activation in tau-expressing neurons via endogenous Z-RNAs derived from transposable elements that are normally silenced in heterochromatin. This links tau pathology to derepression of transposable elements and a defined death pathway, suggesting ZBP1/Z-RNA signaling as a potential therapeutic target in tauopathies.

Liu W, Wu SA, Zhang BX et al. · Nature neuroscience · (2026) · View on PubMed ↗

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

This association study examined whether cytochrome P450 2D6 (CYP2D6) genetic variants modify risk and survival in patients with amyotrophic lateral sclerosis (ALS), in the context of variable riluzole benefit. The key finding was that CYP2D6 poor-function variants were associated with differences in ALS outcomes, consistent with CYP2D6’s role in metabolism of neuroactive drugs and brain expression. Clinically, CYP2D6 genotyping could help explain heterogeneity in survival and potentially inform more personalized ALS treatment strategies.

Vallikivi JK, Kooyman M, Kirby J et al. · Brain : a journal of neurology · (2026) · View on PubMed ↗ · Free PDF ↗

Hyperexcitable VTA-mPFC dopaminergic circuit disrupts sleep spindle and mediates sleep fragmentation after chronic social defeat stress.

This mouse study tested how chronic social defeat stress affects sleep by focusing on the hyperexcitable ventral tegmental area (VTA)–medial prefrontal cortex (mPFC) dopaminergic circuit. Chronic stress increased firing/bursting of VTA dopaminergic neurons, elevated dopamine release in mPFC, and disrupted NREM sleep spindles, with dopamine-pathway blockade during stress or pharmacologic inhibition preventing sleep fragmentation. Scientifically, it links stress-driven VTA-mPFC dopamine signaling to EEG spindle disruption, offering a mechanistic target for stress-related sleep disorders.

Li R, Zhang X, Li J et al. · Neuron · (2026) · View on PubMed ↗

Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study.

This prospective cohort study examined associations between smoking cessation, subsequent weight change, and long-term dementia risk and cognitive trajectories in 32,802 dementia-free adults from the US Health and Retirement Study (1995–2020). It evaluated smoking status and body weight biennially and assessed incident dementia over follow-up using the Langa-Weber classification approach. The study is clinically significant because it clarifies how smoking cessation benefits may interact with post-cessation weight gain in determining dementia risk.

Chen H, Wang J, Lai S et al. · Neurology · (2026) · View on PubMed ↗

---

Neuroinflammation, Neuroimmune & Brain Metastasis Biology

LDHA-mediated CREB1 Lactylation Promotes Breast Cancer Brain Metastasis by Transcriptionally Activating Cytoskeletal Remodeling.

The study used single-cell RNA sequencing (scRNA-seq) and computational analyses (inferCNV and pseudotime trajectory) on paired primary breast tumors and brain metastases to identify high-risk malignant subclusters and therapeutic targets, focusing on LDHA-driven CREB1 lactylation. The key finding was that LDHA-mediated lactylation of CREB1 promotes transcriptional programs for cytoskeletal remodeling that support breast cancer brain metastasis. This suggests a mechanistic metabolic–transcriptional axis (LDHA → CREB1 lactylation) that could be targeted to prevent or treat brain metastatic disease.

Liu S, Bai Z, Qiao Y et al. · Neuro-oncology · (2026) · View on PubMed ↗

---

Microbiome & Infectious Disease (including FMT, viral/bacterial mechanisms)

Scavenger receptor class F member 2 is an intracellular receptor for hepatitis B virus.

The study investigated hepatitis B virus (HBV) entry and trafficking by testing whether the intracellular single-pass transmembrane protein scavenger receptor class F member 2 (SCARF2) serves as an intracellular receptor, focusing on how SCARF2 domains interact with the HBV preS1 region. The authors found that SCARF2 binds a preS1 segment downstream of the NTCP-binding site via its N-terminal EGF-like domains 4–6, and that the proline-rich C-terminal domain is required for infection. This mechanistic identification of SCARF2 as an intracellular HBV receptor expands therapeutic targets beyond NTCP for blocking HBV infection.

Li C, Wang Y, Xiong R et al. · Cell · (2026) · View on PubMed ↗

DNA polymerization activates RNA cleavage of a reverse transcriptase-like antiviral enzyme.

The study investigated how a single defense-associated reverse transcriptase-like enzyme, DRT4, mediates RNA-targeting antiphage defense by integrating DNA polymerase, exonuclease, and RNA endonuclease activities. Key findings showed that infection-associated elevated dNTPs shift DRT4’s polymerase/exonuclease equilibrium toward protein-primed ssDNA synthesis, and that sufficiently long ssDNA together with phage DNA-binding proteins and dGTP activates RNA cleavage. This mechanistic link between DNA polymerization and RNA cleavage clarifies how ncRNA-independent DRT4 antiviral defense can be triggered and regulated during phage infection.

Rong X, Xiao J, Zhao X et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal Carcinoma.

The study assessed whether an Epstein-Barr virus (EBV) BNLF2b gene-encoded antibody test (P85-Ab) for nasopharyngeal carcinoma (NPC) detection performs comparably to a combined EBV-specific IgA antibody score and a circulating EBV DNA algorithm. In a multicenter case-control design in Taiwan (July 2010–December 2014), the key finding was the comparative diagnostic performance of P85-Ab relative to those alternative EBV-based strategies (full comparative metrics are truncated in the abstract). If validated, P85-Ab could improve early NPC detection by providing an antibody-based test with performance comparable to or better than existing EBV DNA/IgA approaches.

Hsu WL, Tang J, Lam HY et al. · JAMA otolaryngology— head & neck surgery · (2026) · View on PubMed ↗

Ankylosing spondylitis and the gut microbiome: future research hotspots and trends.

This bibliometric analysis systematically reviewed and visualized research trends on ankylosing spondylitis (AS) and the gut microbiome up to January 1, 2026 using Web of Science and PubMed. The key finding was the mapping of current research hotspots and future directions linking gut microbiota to AS pathogenesis. Such trend synthesis can help prioritize mechanistic and translational studies targeting microbiome-driven pathways in AS.

Yin X, Peng H, Li Y et al. · Frontiers in immunology · (2026) · View on PubMed ↗ · Free PDF ↗

Fecal microbiota transplantation for symptom improvement in patients with irritable bowel syndrome: systematic review and meta-analysis of randomized controlled trials.

This systematic review and meta-analysis studied randomized controlled trials of fecal microbiota transplantation (FMT) for symptom improvement in irritable bowel syndrome (IBS), pooling evidence for outcomes assessed 4–24 weeks after FMT. The key finding was an overall estimate of IBS symptom improvement (expressed as risk ratios for not improved) with quantified certainty of evidence using GRADE. Scientifically and clinically, it clarifies the current effectiveness signal of FMT in IBS and highlights the strength/limitations of the evidence base for practice decisions.

Aumpan N, Watanabe J, Yuan Y et al. · Gastroenterology · (2026) · View on PubMed ↗

A pathogen lncRNA secreted into rice sequesters a host miRNA for virulence.

This study examined how a fungal pathogen lncRNA secreted into rice cells promotes virulence by RNA–RNA recognition that sequesters a host microRNA. The key finding is that Magnaporthe oryzae translocates a pathogen-derived long non-coding RNA into rice, where it binds and sequesters a complementary host miRNA to suppress host immunity. This is significant because it reveals a non-protein effector mechanism that could be exploited to develop RNA-targeted strategies for controlling rice blast disease.

He M, Su J, Zhou X et al. · Nature · (2026) · View on PubMed ↗ · Free PDF ↗

Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxins.

This study developed multivalent nanobodies (Nbs) against Staphylococcus aureus toxins, targeting Hla and T-cell superantigens SEB, SEC, and TSST-1, and characterized their binding and neutralization using cryo-EM and AlphaFold3. The key finding is that nanobodies elicited with clinical cocktail vaccines achieved potent, broad neutralization through diverse epitopes and mechanisms revealed by structural analyses. Scientifically and therapeutically, this supports nanobody-based immunotherapy and informs vaccine design aimed at neutralizing multiple S. aureus virulence factors.

Kim YJJ, Walton NR, Huang W et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Epigenetic phase variation in the gut microbiome enhances bacterial adaptation.

This Cell Host & Microbe study characterized epigenetic phase variation (ePV) in the gut microbiome and how it enhances bacterial adaptation to environmental changes. By cataloging ePV in infant and adult microbiomes and using long-read metagenomics, it found genome-wide and site-specific ePV in response to antibiotics and fecal microbiota transplantation, with genome-wide ePV mediated by structural variation of DNA methyltransferases. These findings suggest that epigenetic heterogeneity is a widespread adaptation mechanism in commensal gut bacteria.

Ni M, Junker K, Liu Y et al. · Cell host & microbe · (2026) · View on PubMed ↗

A CRISPR activation screen identifies SPART as a pan-orthoflavivirus restriction factor.

This Cell Host & Microbe study used a genome-wide CRISPR activation screen to identify host restriction factors against orthoflaviviruses. It identified SPART (Spartin/SPG20) as a pan-orthoflavivirus restriction factor that interacts with and disrupts ITCH endosomal localization, thereby affecting ITCH-mediated ubiquitination of the Zika virus capsid and uncoating. Loss of SPART increased ZIKV replication, highlighting SPART as a potential antiviral target.

Li Q, Yin Y, Liu Y et al. · Cell host & microbe · (2026) · View on PubMed ↗

Streptococcus pneumoniae: Pathogenesis, virulence factors, antimicrobial resistance mechanisms, and therapeutic strategies.

This review studied Streptococcus pneumoniae pathogenesis and virulence, focusing on how adaptive recombination drives immune evasion and antimicrobial resistance despite vaccines and antibiotic pressure. It synthesized current evidence on pneumococcal virulence factors, resistance mechanisms, and therapeutic strategies for community-acquired pneumonia, meningitis, bacteremia, and otitis media. The work is scientifically significant because it frames ongoing disease burden as an evolutionary response to vaccination and antimicrobials, informing future treatment and prevention approaches.

Woodard GE · Diagnostic microbiology and infectious disease · (2026) · View on PubMed ↗

Post-Infectious Fatigue and Depression Following Dengue: A Systematic Review and Meta-Analysis of Associated Factors.

This systematic review and meta-analysis studied factors associated with post-infectious fatigue and post-dengue depression in people after dengue infection. The key finding is that the review compared and synthesized demographic and clinical/biologic associations to distinguish and identify contributors to post-dengue fatigue syndrome versus post-dengue depression. Clinically, it supports improved recognition and differentiation of long-term post-dengue sequelae that can otherwise be confused due to overlapping symptoms.

Condé A, Maillard O, Rodrigo C et al. · Reviews in medical virology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cardiovascular Prevention & Risk Prediction (including diabetes/heart failure)

Macrophage EHD1 Promotes Inflammation and Stabilizes Sortilin to Accelerate Atherosclerosis.

The study examined how macrophage EHD1 (Eps15 homology domain-containing protein 1) regulates inflammatory signaling and stabilizes sortilin to accelerate atherosclerosis. The key finding was that EHD1 promotes proinflammatory macrophage responses and stabilizes the sortilin receptor, thereby enhancing processes linked to atherosclerosis progression (full experimental details are truncated). These findings identify the EHD1–sortilin axis as a potential therapeutic target to modulate macrophage-driven inflammation in atherosclerotic disease.

Ma F, Liu Y, Xu Y et al. · Circulation research · (2026) · View on PubMed ↗

Interplay of Multipathway Dyslipidemia, Inflammation, and Cholesterol-Lowering Medication in Modifying Abdominal Aortic Aneurysm Risk.

The study analyzed how dyslipidemia components (LDL-C, lipoprotein[a] [Lp(a)], and remnant cholesterol [RC]) interact with systemic inflammation to modify abdominal aortic aneurysm (AAA) risk under widespread cholesterol-lowering medication use. Using prospective data from 338,758 UK Biobank participants free of AAA at baseline and Cox proportional hazards models, the key finding was the joint and pathway-specific associations between these lipid fractions, inflammation markers, and incident AAA risk (exact hazard ratios are truncated). This helps clarify which lipid fractions and inflammatory states confer the greatest residual AAA risk even in the era of cholesterol-lowering therapy.

Wu Y, Chen D, Zhang Y et al. · Arteriosclerosis, thrombosis, and vascular biology · (2026) · View on PubMed ↗

GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity.

The study evaluated whether glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated with lower risk of intracranial aneurysm rupture and reduced rupture severity. Using a retrospective cohort design in the TriNetX US Collaborative Network (2016–2024) with cohorts of newly diagnosed untreated unruptured intracranial aneurysms (UIAs) and patients who experienced rupture, the key finding was an association between GLP-1RA use and reduced rupture risk and attenuated severity (detailed effect sizes are truncated). Clinically, this suggests GLP-1RA therapy may have vasculoprotective benefits relevant to aneurysm stability and outcomes after subarachnoid hemorrhage.

Chen H, McIntyre MK, Kakadiya J et al. · Stroke · (2026) · View on PubMed ↗

Aldosterone synthase inhibitors: a new option for antihypertensive, cardio-renal protection.

This article reviewed selective aldosterone synthase inhibitors—baxdrostat, lorundrostat, and vicadrostat—as antihypertensive agents and cardio-renal protective drugs in conditions driven by aldosterone–salt imbalance, focusing on their pharmacologic selectivity versus 11β-hydroxylase. The key finding is that these drugs inhibit aldosterone synthase with minimal 11β-hydroxylase activity, supporting both blood-pressure lowering and aldosterone-mediated organ protection via mineralocorticoid receptor pathway blockade. Clinically, this positions aldosterone synthase inhibition as an emerging strategy for chronic heart failure, chronic kidney disease, and vascular disorders where aldosterone contributes to organ damage beyond hemodynamics.

Sato A, Nishimoto M · Hypertension research : official journal of the Japanese Society of Hypertension · (2026) · View on PubMed ↗ · Free PDF ↗

Preservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study.

This study analyzed associations between preservative food additive intake and incidence of hypertension and cardiovascular diseases (CVD) in the NutriNet-Santé cohort in France from 2009–2024, using repeated 24-hour dietary records and exposure estimation from composition databases plus laboratory assays. The key finding (not fully shown due to truncation) is that cumulative, time-dependent exposure to preservative additives was evaluated for links to later hypertension/CVD risk. Scientifically and clinically, it addresses a major gap in human evidence for potential cardiovascular harms of preservative additives suggested by experimental studies.

Hasenböhler A, Javaux G, Payen de la Garanderie M et al. · European heart journal · (2026) · View on PubMed ↗

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

This model development and validation study studied precision prescribing of SGLT2 inhibitors for primary prevention of heart failure in individuals with type 2 diabetes without ASCVD, heart failure, or chronic kidney disease. The key finding is the creation of the SGLT2i Absolute Benefit Response (SABRE) model to predict individual-level absolute heart-failure benefit using patient risk estimates. Clinically, it aims to identify which otherwise “lower-risk” T2D patients are most likely to benefit from SGLT2 inhibitors, enabling more targeted preventive therapy.

Young KG, McGovern AP, Hopkins R et al. · Diabetes care · (2026) · View on PubMed ↗

---

Perioperative/Procedural Safety & Monitoring (fluids, anticoagulation, ERCP, etc.)

Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models.

The study developed a high phosphatidylserine (PS)-exposed procoagulant platelet (hPPL) derivative reprogrammed from isolated platelets using calcium ionophore A23187-induced apoptosis, and tested it in human- and rat-derived plasma and whole blood. hPPL retained a resting-platelet-like protein profile while robustly promoting platelet activation/aggregation and driving rapid hemostasis via PS and prostaglandin E2 (PGE2) signaling, outperforming clinical thrombin and a commercial hemostatic comparator in preclinical models. These results support a PS/PGE2-based platelet reprogramming strategy as a potential rapid hemostatic therapy, including for patients at risk of uncontrolled bleeding such as those on antiplatelet drugs.

Wang P, Du S, Wu S et al. · Science translational medicine · (2026) · View on PubMed ↗

How to monitor and manage unfractionated heparin in practice (Part 1): Guidance from the SSC of the ISTH.

This guidance document studied how to monitor and manage unfractionated heparin (UFH) in clinical practice by synthesizing evidence and reaching consensus through a Delphi process from the ISTH SSC. The key finding was practical, evidence-based recommendations for preanalytical, analytical, and clinical aspects of UFH monitoring, including sample handling timing and acceptable centrifugation/testing windows. This is clinically significant because it aims to reduce variability in UFH management and improve safety by standardizing laboratory and bedside processes.

Gouin-Thibault I, Frere C, Castellucci LA et al. · Journal of thrombosis and haemostasis : JTH · (2026) · View on PubMed ↗

Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial.

This randomized controlled trial studied timing of endoscopic retrograde cholangiopancreatography (ERCP) in patients with mild-to-moderate acute cholangitis, comparing urgent ERCP within 24 hours versus early ERCP within 24–48 hours. The trial’s primary outcome was 30-day mortality, with secondary outcomes including organ failure at day 3 and day 30, in-hospital mortality, length of stay, reintervention, readmission, and post-ERCP adverse events (results truncated in abstract). The clinical significance is that it directly tests whether earlier ERCP timing improves survival and complications in this cholangitis severity group.

Jagtap N, Rughwani H, Talukdar R et al. · Gut · (2026) · View on PubMed ↗

Hydroxyethyl Starch and Perioperative Complications: a Systematic Review and Meta-analysis.

This systematic review and meta-analysis studied perioperative hydroxyethyl starch (HES 130/0.4) and its complications, with emphasis on renal injury outcomes in surgical patients. The key finding is that, building on prior evidence, the authors added 45 trials (6895 patients) and focused on acute kidney injury and perioperative creatinine changes to reassess risk. Scientifically and clinically, the updated synthesis informs perioperative fluid-management decisions in light of regulatory warnings and withdrawals related to HES.

Sessler DI, Pradelli L, Povero M et al. · Anesthesiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Rheumatology & Autoimmune Disease (GCA/PMR, ILD, etc.)

Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.

This systematic review and pooled multicenter real-world cohort study investigated triple therapy combining nintedanib with dual immunosuppression in patients with interstitial lung disease (ILD) associated with systemic sclerosis (SSc) or rheumatoid arthritis (RA). The key finding was characterization of effectiveness and safety/tolerability outcomes using longitudinal changes in lung function measures such as % predicted FVC and % predicted DLCO (and mRSS in SSc). Clinically, it informs real-world feasibility and risk-benefit considerations for this intensified regimen in high-mortality connective-tissue–associated ILD.

Chioni A, Campochiaro C, Keret S et al. · Autoimmunity reviews · (2026) · View on PubMed ↗

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.

This review summarized current and emerging treatment strategies for giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) beyond glucocorticoids, emphasizing immunopathology-driven targeted therapies. It highlights IL-6 pathway inhibition as a key advance and notes more recent use of the JAK inhibitor class (including a Janu* agent) to reduce relapse and glucocorticoid-related morbidity. Clinically, the synthesis supports more steroid-sparing, mechanism-based management for GCA/PMR to limit ischemic complications and treatment toxicity.

Muratore F, Warrington KJ, Dejaco C et al. · Nature reviews. Rheumatology · (2026) · View on PubMed ↗

---

Allergy, Asthma & Dermatology Therapeutics

Biomarker-Defined Endotypes and Clinical Phenotypes of Asthma: A Cluster-Based Analysis of Type-2 Inflammatory Patterns and Their Clinical Correlates.

This cross-sectional study used unsupervised clustering to define biomarker-defined asthma endotypes based on type-2 (T2) inflammatory patterns and to relate them to clinical and demographic features in real-world asthmatic patients. The key finding was the identification of distinct asthma endotypes reflecting overlap between allergic and eosinophilic pathways and their associated clinical correlates, derived from biomarker-driven clustering. This endotype framework could improve precision phenotyping and guide more targeted management of T2-driven asthma.

Feteih IHE, Ali A · Journal of asthma and allergy · (2026) · View on PubMed ↗ · Free PDF ↗

Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series.

This Spanish multicentric case series assessed the efficacy and safety of dupilumab, an IL-4/IL-13 signaling blocker, for immune checkpoint inhibitor (ICI)-induced bullous pemphigoid (BP) in patients treated with ICIs. The key finding was that dupilumab was used as an alternative to conventional glucocorticoids and other immunosuppressants to achieve BP control while potentially reducing toxicity and minimizing disruption of antitumor responses. This supports dupilumab as a promising management option for ICI-associated BP, a serious adverse event that can otherwise force cancer therapy discontinuation.

Tejero-García C, Alamon Reig F, Bosch-Amate X et al. · Acta dermato-venereologica · (2026) · View on PubMed ↗ · Free PDF ↗

Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

This post-hoc secondary analysis evaluated absolute Eczema Area and Severity Index (EASI) responses (EASI thresholds ≤7, ≤5, ≤3, ≤1) in adults/adolescents with moderate-to-severe atopic dermatitis receiving lebrikizumab (LEB) monotherapy from the ADvocate phase 3 trials (NCT04146363 and NCT04178967). The key finding was the characterization of how many patients achieved clinically meaningful absolute EASI response levels, complementing the trials’ original percent EASI improvement metric. This helps translate lebrikizumab efficacy into absolute disease-state outcomes that are commonly used in clinical practice.

Thaçi D, Puig L, Motegi SI et al. · Acta dermato-venereologica · (2026) · View on PubMed ↗ · Free PDF ↗

Methodology and baseline characteristics of the China Migraine registry (CHIME): a nationwide, multi-center, prospective cohort study of 11,814 patients.

The China Migraine Registry (CHIME) methodology paper studied how a nationwide, multi-center, prospective cohort of 11,814 patients across >100 specialized headache centers in 28 Chinese provinces was designed to capture diagnostic accuracy and treatment patterns for migraine. The key finding was the establishment of a standardized real-world evidence platform with detailed baseline clinical characterization and planned assessment of diagnostic and therapeutic practices. This is scientifically significant because it enables large-scale, generalizable evaluation of migraine management quality and outcomes in China.

Ran Y, He Z, Han X et al. · The journal of headache and pain · (2026) · View on PubMed ↗ · Free PDF ↗

Efficacy, Tolerance, and Safety of a Novel Botanical Anti-Inflammatory Moisturizer in Rosacea: Results From a Double-Blinded, Randomized Controlled Trial.

This double-blinded randomized controlled trial studied a novel topical botanical anti-inflammatory moisturizer containing oat and aloe versus 0.75% metronidazole cream in 60 adults with mild-to-severe rosacea over 12 weeks. The key finding was that the moisturizer improved investigator global assessment of erythema and inflammatory lesion counts with comparable tolerability to the active comparator. Clinically, this suggests a potential non-antibiotic topical option for rosacea symptom control and skin tolerability.

Draelos ZD · Journal of cosmetic dermatology · (2026) · View on PubMed ↗ · Free PDF ↗

Endometriosis-related alterations in the endometrium revealed by integrated single-cell and AI-powered approaches.

The study investigated endometriosis-related changes in the human endometrium by generating an integrated single-cell atlas (466,371 cells) from 35 endometriosis and 25 non-endometriosis donors without exogenous hormonal treatment, and then applying an AI-powered analysis tool (ScaiVision). It found significant gene expression differences and altered receptor–ligand interactions in endometriosis, including increased inflammation, adhesion, proliferation, cell survival, and angiogenesis across multiple cell types. Clinically, these atlas-derived alterations and predicted targets may improve understanding of lesion formation and support development of diagnostic or therapeutic strategies for endometriosis.

Duempelmann L, Sheppard S, McKinnon B et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Interleukin-4-producing type 2 innate lymphoid cells in the lymph node promote proallergic Tfh13 cell differentiation.

This Immunity study investigated the cellular determinants of proallergic Tfh13 differentiation during allergic sensitization, focusing on lymph node group 2 innate lymphoid cells (ILC2s). Using orthogonal genetic and bone marrow chimera approaches, it found that ILC2s in draining lymph nodes promote Tfh13 differentiation, with trafficking controlled by chemokine receptor signaling. The results clarify how ILC2s orchestrate allergen-driven Tfh13 development, informing strategies to modulate IgE-mediated allergy.

Lee D, Lu MP, Rajamanimuthu P et al. · Immunity · (2026) · View on PubMed ↗ · Free PDF ↗

Childhood Vaccine Hesitancy.

This narrative article studied childhood vaccine hesitancy as a spectrum of concerns and evaluated communication approaches that clinicians can use to improve uptake. It emphasized that clinicians are the most trusted source of vaccine information and that presumptive communication and empathy-driven, patient-centered strategies (including motivational interviewing) are more effective than open-ended approaches. The clinical significance is that it provides actionable guidance for addressing safety concerns and improving routine childhood immunization rates.

O’Leary ST, Danchin M · The New England journal of medicine · (2026) · View on PubMed ↗

---

Ophthalmology & Ocular Oncology

Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma.

This final 5-year analysis studied overall survival in previously untreated HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma treated with tebentafusp versus investigator’s choice of pembrolizumab, ipilimumab, or dacarbazine in an international open-label phase 3 trial. The key finding was that tebentafusp maintained an overall survival benefit over the control treatments at 5 years. This is significant because it confirms durable long-term efficacy and supports tebentafusp as first-line standard of care for this biomarker-defined population.

Piperno-Neumann S, Rutkowski P, Hassel JC et al. · Annals of oncology : official journal of the European Society for Medical Oncology · (2026) · View on PubMed ↗

---

Neuromuscular & Genetic Disorders (SMA, cancer predisposition, diabetes screening)

Screening Children for Early-Stage Type 1 Diabetes.

The study estimated the prevalence of early-stage (stage 1 or 2) type 1 diabetes and progression to clinical stage 3 in children using a population-based screening program in Bavaria, Germany. The key finding was the quantified prevalence and progression rates of early-stage type 1 diabetes detected through serial screening by 716 primary care pediatricians (specific prevalence/progression numbers are truncated in the abstract). Scientifically and clinically, these data inform how effective presymptomatic screening could be for enabling interventions aimed at delaying onset of clinical type 1 diabetes.

Winkler C, Friedl N, Abt R et al. · JAMA · (2026) · View on PubMed ↗

Enhanced splicing modulation by NMA-modified antisense oligonucleotides.

The study evaluated the next-generation ribose modification 2’-O-[2-(methylamino)-2-oxoethyl] (NMA) in splice-switching antisense oligonucleotides (SSOs), focusing on the human candidate salanersen versus nusinersen in human SMN2 transgenic mice. NMA-modified salanersen was identified as a long-lasting SSO that was three to four-fold more potent than nusinersen in this SMN2 model. This supports NMA chemistry as a strategy to improve potency and durability of therapeutic splice modulation for spinal muscular atrophy.

Ling K, Prakash TP, Yu J et al. · Nucleic acids research · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study.

This international retrospective observational study characterized the phenotypic spectrum and genetic determinants of severe spinal muscular atrophy (SMA) in individuals with genetically confirmed biallelic SMN1 variants and exactly one SMN2 copy, recruited from 36 Italian neuromuscular centers plus additional centers. The key finding was that even with a single SMN2 copy—typically associated with the most severe SMA—there is a measurable phenotypic heterogeneity, with associations explored between genotype and clinical outcomes. Clinically, this refines prognostication for severe SMA and highlights that factors beyond SMN2 copy number contribute to disease severity.

Cicala G, Capasso A, Villa M et al. · EClinicalMedicine · (2026) · View on PubMed ↗ · Free PDF ↗

Pathogenic germline variations and cancer risks in pediatric patients referred for genetic testing.

The study analyzed exome sequencing data from 75,602 pediatric patients referred for genetic testing (2016–2025) to quantify cancer predisposition risks associated with germline pathogenic variants in tumor susceptibility genes. Among 110,692 variants across 139 cancer predisposition genes, 501 variants (0.45%) were identified as cancer-related secondary findings, including single-nucleotide variants and copy number variations. This large pediatric cohort refines estimates of cancer risk from germline findings and informs genetic counseling and surveillance strategies.

Wang H, Dong X, Xiao F et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

---

Genome Editing & Precision Bioengineering (prime editing, CRISPR delivery, nanocages/cages)

De novo design of miniproteins targeting GPCRs.

The study used computational de novo protein design and a high-throughput “receptor diversion” microscopy-based screen to generate GPCR-binding miniprotein agonists and antagonists targeting itch/pain and cancer/metabolic disorder/migraine-relevant receptors. The authors report miniproteins with high affinity, potency, and selectivity, including agonists that activate itch and pain GPCRs and antagonists that inhibit GPCRs implicated in cancer, diabetes/obesity, and migraine. This provides a scalable platform for engineering next-generation GPCR modulators beyond conventional small-molecule or antibody approaches.

Muratspahić E, Feldman D, Kim DE et al. · Nature · (2026) · View on PubMed ↗

Optimized lentivirus-derived virus-like particles for efficient delivery of Cas9-based genome editors.

The study developed and optimized an LV-VLP-MA lentivirus-derived virus-like particle platform for delivering Cas9 ribonucleoproteins and Cas9-derived base editors/prime editors in vivo. By engineering truncated Gag–Cas9 fusion variants, the authors identified a minimal MA-Cas9 configuration that maximized editor packaging while preserving particle production and functional delivery, and they further improved VLP production parameters to increase yield. This provides a more efficient, transient, and flexible protein-editing delivery system that could broaden therapeutic genome editing applications.

Liu B, Klatt D, Harris C et al. · Nucleic acids research · (2026) · View on PubMed ↗ · Free PDF ↗

Design of one-component quasisymmetric protein nanocages.

This work studied the computational design of one-component quasisymmetric protein nanocages built from a single chemically identical subunit that must adopt multiple conformations in non-equivalent positions. The key finding is a design framework enabling quasisymmetric assemblies beyond strictly symmetric 60-subunit icosahedra, addressing the challenge of engineering identical building blocks to form distinct interfaces. This is scientifically significant for nanomedicine because one-component quasisymmetric cages could provide large internal volumes for delivery of biologics with simpler manufacturing than multi-component systems.

Lee S, Chmielewski D, Wang S et al. · Nature · (2026) · View on PubMed ↗

A deep-learning framework reveals whole-body perturbations at cell level.

This study developed MouseMapper, a deep-learning framework using foundation models to quantify whole-body perturbations at cellular resolution in mice. The key finding is that MouseMapper segments 31 organs/tissues and resolves nerves and immune-cell clusters, enabling detection of diet-induced obesity–associated structural alterations across multiple systems. This is scientifically significant because it provides a high-resolution, system-wide phenotyping tool that can accelerate mechanistic studies of complex diseases like obesity.

Kaltenecker D, Horvath I, Al-Maskari R et al. · Nature · (2026) · View on PubMed ↗ · Free PDF ↗

De novo design of quasisymmetric two-component protein cages.

This work studied de novo computational design of quasisymmetric two-component protein cages that co-assemble from complementary trimeric and dimeric components. The key finding is a geometric-frustration-based strategy that yields quasisymmetric cages with customizable properties by assembling local hexagonal arrangements from two different subunit types. This is significant for nanotechnology because it expands the design space for viral-capsid-like architectures that can be tuned for delivery and materials applications.

Wang S, Xie Y, Chemielewski D et al. · Nature · (2026) · 1 citations · View on PubMed ↗

Accurate, scalable and cross-platform cell identification for high-resolution spatial transcriptomics.

The study developed and evaluated Cellist, a multi-modal, cross-platform cell-segmentation method for high-resolution spatial transcriptomics in mouse tissue datasets. Cellist integrates image and gene-expression information to enable accurate, scalable cell identification across large fields of view, addressing platform-specific segmentation limitations. This improves the reliability of single-cell spatial analyses and cell-cell interaction mapping for next-generation spatial transcriptomics workflows.

Sun D, Zhang L, Han T et al. · Nature genetics · (2026) · View on PubMed ↗

Directed evolution of small RNA-stabilizing motifs that improve prime-editing efficiency.

The study engineered and optimized prime editing (PE) by targeting structured small RNA motifs appended to the 3’ end of pegRNAs, using a pooled high-throughput screen in human cells. Using PE-PRISM, the authors evaluated 2,858 RNA motifs across four iterative libraries (including pseudoknots, G-quadruplexes, and reverse transcriptase recruitment elements) and identified motif variants that improve pegRNA stability and prime-editing efficiency. This provides actionable RNA design rules to increase PE performance for more effective genome editing.

Sakai HA, Pierce SE, Jiang AY et al. · Nature biotechnology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Metabolic, Aging & Translational Biology (including diet, lactate, organelle function)

Complex interplay of neuronal and hormonal gut-brain responses to essential amino acid deficit.

The study dissected neuronal and hormonal gut–brain mechanisms driving essential amino acid (EAA)-specific appetite in Drosophila under dietary EAA deficit. The key finding was that EAA deprivation induces CNMamide (CNMa) expression in gut enterocytes, activating enteric and ellipsoid body neurons via a rapid neuronal gut–brain axis and a slower hormonal route, with CNMa suppressing DH44 neurons to reduce carbohydrate intake and bias feeding toward EAAs. This is significant because it identifies a defined gut–brain signaling circuit (CNMa → DH44 modulation) that governs nutrient-specific feeding behavior.

Kim B, Lee S, Bae H et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

FERONIA orchestrates plasma membrane nanoclusters for plant thermotolerance.

The study investigated how the malectin-like receptor kinase FERONIA (FER) controls plasma membrane nanoclusters to promote plant thermotolerance in Arabidopsis, using the RALF34 peptide as an activating cue. The key finding was that moderate heat activates FER through RALF34, recruiting FER to sterol-rich nanodomains where FER nucleates dynamic stress-signaling nanoclusters that stabilize liquid-ordered membrane phases and activate heat-shock transcription factor outputs. This is significant because it links membrane nanocluster organization to heat-adaptation signaling, identifying FER as a membrane-anchored “thermal switch” for thermotolerance.

Wang K, Yan H, Guo X et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Multi-Omics Profiling Reveals Immunomodulatory and Pro-Regenerative Effects of a Graphene Oxide-Collagen Scaffold in Massive Rotator Cuff Tears.

The study investigated a graphene oxide (GO)-engineered porcine type I collagen scaffold (GO/Col) for massive rotator cuff tears (MRCT) and used multi-omics profiling to define immunomodulatory and pro-regenerative mechanisms. Key findings showed that GO incorporation improved scaffold stability, wettability, and biocompatibility and that multi-omics analyses supported immunomodulatory and regenerative pathway activation in the context of tendon-bone interface (TBI) healing and muscle degeneration (detailed pathway results are truncated). This supports GO/Col tissue engineering as a mechanistically guided biomaterial strategy to reduce retear risk by improving coordinated TBI regeneration.

Wan R, Deng Y, Hu Z et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · (2026) · View on PubMed ↗ · Free PDF ↗

Microalgae extracellular vesicles-loaded dual antioxidative and anti-inflammatory hydrogel system for wound healing and peripheral nerve repair in diabetes.

The study developed a multifunctional hydrogel (mEVs@TAgel) for diabetic wound healing and peripheral nerve repair by co-delivering microalgae extracellular vesicles (mEVs) from Haematococcus pluvialis and tannic acid (TA). The key finding was that the hydrogel provided injectability, strong tissue adhesion, and sustained mEV release, while combining mEV cargo (including astaxanthin and functional proteins targeting mitochondrial dysfunction/oxidative stress) with TA’s antioxidant and anti-inflammatory effects to address diabetic regenerative barriers. This supports a dual antioxidative/anti-inflammatory extracellular-vesicle hydrogel strategy as a potential therapeutic platform for diabetic tissue repair.

Dong J, Cheng B, Zhang X et al. · Bioactive materials · (2026) · View on PubMed ↗ · Free PDF ↗

Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study.

Using EPIC (European Prospective Investigation into Cancer and Nutrition) data from 450,112 participants followed for 14.1 years, this study examined whether red, processed, and white meat intake is associated with gastric adenocarcinoma by anatomical site and histological type and with esophageal adenocarcinoma. The key finding was that meat consumption showed differential associations with gastric and esophageal adenocarcinoma risk depending on meat type and tumor subtype/location. This is significant for refining dietary risk stratification and informing prevention strategies targeting specific upper gastrointestinal cancer subtypes.

Bonet C, Rizzolo-Brime L, Montañés S et al. · International journal of cancer · (2026) · View on PubMed ↗ · Free PDF ↗

Mitochondrial L-2-hydroxyglutarate is a physiological signalling metabolite.

This study investigated whether mitochondrial L-2-hydroxyglutarate (L-2-HG) functions as a physiological signalling metabolite, using biochemical and cellular criteria including regulated levels, defined molecular targets, and measurable physiological effects. The authors report that L-2-HG increases mitochondrial NADH/NAD+ ratio and identifies physiological signalling properties rather than treating L-2-HG solely as a toxic byproduct. This is scientifically significant because it reframes L-2-HG biology and clarifies how mitochondrial metabolism can generate signalling outputs relevant to disorders such as L-2-hydroxyglutaric aciduria caused by L2HGDH deficiency.

Chakrabarty RP, Van Vranken JG, Aoi Y et al. · Nature · (2026) · View on PubMed ↗ · Free PDF ↗

Genetic analysis of circulating metabolic traits in 619,372 individuals.

This genome-wide association study performed a meta-analysis of genetic variants with 249 circulating metabolic traits in up to 619,372 individuals from the Estonian Biobank and UK Biobank. It identified 88,127 common and low-frequency locus–trait associations across 8,398 loci that converge on shared genes and pathways, supported by fine mapping and phenome-wide colocalization. The findings are clinically significant because they improve interpretation of GWAS signals for metabolic biomarkers and complex disease mechanisms by linking variants to molecular pathways.

Tambets R, Jesse M, Kronberg J et al. · Nature · (2026) · View on PubMed ↗ · Free PDF ↗

A SAUR gene enhances maize drought resilience by promoting silk elongation.

This study investigated the role of a specific small gene in maize drought tolerance by cloning and characterizing a SAUR gene (qDR9) that promotes silk elongation under drought. The key finding is that the SAUR gene enhances drought resilience by shortening the drought-induced anthesis–silking interval (ASI), thereby improving reproductive success during flowering drought stress. This is agriculturally significant because it provides a candidate gene for breeding or engineering maize varieties with improved yield stability under drought.

Zhu C, Yang Z, Yang S et al. · Nature · (2026) · View on PubMed ↗

Peroxisomes orchestrate metabolic flexibility and longevity via an interorganelle cascade.

The study investigated how peroxisomes regulate metabolic flexibility and longevity in the nematode Caenorhabditis elegans, focusing on peroxisomal import mediated by PRX-5 across youth versus aging and under fasting. Fasting in youth robustly induces peroxisomal function, whereas this induction is blunted with age due to age-related decline in PRX-5, leading to lipid droplet expansion, impaired mitochondrial bioenergetics, and metabolic inflexibility. These findings identify peroxisomal import (PRX-5) as a temporal driver of organelle dysfunction and suggest a mechanistic target for promoting healthy aging.

Sharma A, Prabhakar A, Valera-Alberni M et al. · Nature aging · (2026) · View on PubMed ↗ · Free PDF ↗

In situ cryo-ET defines the ultrastructure of ER exit sites in human cells.

The study used in situ cryo-electron tomography combined with super-resolution fluorescence microscopy to define the ultrastructure of ER exit sites in human cells. It revealed the molecular architecture and organization of ER-to-Golgi transport carriers, addressing debates about how COPII-coated vesicles form and are organized in mammalian cells. This provides a structural framework for understanding secretory pathway biogenesis and cargo trafficking in human biology.

Downes KW, Flood JR, Nans A et al. · Nature cell biology · (2026) · View on PubMed ↗ · Free PDF ↗

Autoinhibitory feedback preserves intestinal stem cell maintenance and fate commitment.

The study investigated how the zinc-finger transcription factor Chronophage (Cph) regulates intestinal stem cell (ISC) maintenance and lineage commitment in the Drosophila midgut, using genetic perturbations and single-cell transcriptomics. Cph is induced transiently by the proneural factor scute at the onset of ISC-to-enteroendocrine (EE) specification and functions as an autoinhibitory, self-limiting transcriptional program that preserves ISC maintenance while enabling EE differentiation and normal lifespan. These findings define a conserved-like feedback logic coupling stem cell renewal to differentiation, providing a mechanistic framework for how transcriptional timing controls gut epithelial homeostasis.

Redhai S, Hirschmüller N, Wang T et al. · The EMBO journal · (2026) · View on PubMed ↗ · Free PDF ↗

Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.

This review summarized evidence on how lactate metabolism and lactylation (a lactate-derived post-translational modification) contribute to cancer biology, including tumor initiation, proliferation, invasion, metastasis, recurrence, and drug resistance. The key finding is that lactate is not merely a glycolytic byproduct but actively shapes the tumor microenvironment, modulates immune responses, and drives epigenetic/transcriptional regulation through lactylation of histone and nonhistone targets. The scientific significance is that lactate/lactylation pathways emerge as actionable therapeutic nodes, potentially enabling metabolic-epigenetic combination strategies for cancer treatment.

Fang C, Zhou S, Yu K et al. · Signal transduction and targeted therapy · (2026) · View on PubMed ↗ · Free PDF ↗

Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis.

This systematic review and meta-analysis evaluated randomized controlled trials in adults (≥18 years) not receiving osteoporosis drug therapy to test whether calcium, vitamin D, or combined supplementation reduces fractures and falls. Across included trials, supplementation effects were assessed for risk of any fracture as the primary outcome and falls as secondary outcomes. These findings are clinically important for guiding fracture- and fall-prevention strategies in non–drug-treated adult populations.

Massé O, Mercurio CM, Dupuis S et al. · BMJ (Clinical research ed.) · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

Methionine Restriction Extends Yeast Lifespan by Activating Non-Nitrogen-Starvation-Induced Autophagy Through Limiting Methylation of Protein Phosphatase 2A.

This study investigated how methionine restriction (MR) extends lifespan in budding yeast by mechanistically linking reduced methionine conversion to S-adenosylmethionine (SAM) with changes in protein phosphatase 2A (PP2A) methylation. Under MR, unmethylated PP2A fails to dephosphorylate Npr2 (a SEACIT complex component), thereby activating non-nitrogen-starvation-induced autophagy and extending chronological and replicative lifespans. The findings are scientifically significant because they identify a specific methylation-dependent PP2A→Npr2→autophagy pathway as a targetable antiaging mechanism.

Birmingham K, Arslanovic N, Grauer T et al. · Aging cell · (2026) · View on PubMed ↗ · Free PDF ↗

From mechanistic modeling to AI-driven design: computational strategies for targeting the γ-secretase complex.

This article studied computational strategies for targeting the γ-secretase complex, motivated by the limitations of traditional γ-secretase inhibitors due to off-target toxicity from disrupted Notch signaling. It reviewed and evaluated integrative computational approaches that connect mechanistic modeling with AI-driven drug design to improve next-generation targeting of γ-secretase. The scientific significance lies in providing a framework for designing safer γ-secretase modulators by leveraging computational methods to better understand substrate-specific and off-target effects.

Das S, Rao Padubidri S, K V S et al. · Briefings in bioinformatics · (2026) · View on PubMed ↗ · Free PDF ↗

---

---

Generated automatically on May 22, 2026 from PubMed’s trending articles. Summaries are AI-generated; always consult the original publication for clinical or research decisions.